Combined Immunodeficiency With Inflammatory Bowel Disease in a Patient With TTC7A Deficiency
Overview
Authors
Affiliations
Tetratricopeptide repeat domain-7A (TTC7A) deficiency causing combined immunodeficiency with inflammatory bowel disease (IBD) is rare. This case report alerts physicians to the possibility of TTC7A deficiency causing combined immunodeficiency with IBD and also highlights some of the current treatment options. We describe a 19-year-old patient with a compound heterozygote mutation causing combined immunodeficiency, IBD, and multiple intestinal atresia. Compound heterozygote mutations are known to cause combined immunodeficiency and IBD. Although rare, clinicians should be alerted to this variant and should understand the general approach to treatment.
Huang Z, Zhi X, Geng Q, Yuan X, Zhao X, Qin Q Clin Rev Allergy Immunol. 2025; 68(1):7.
PMID: 39873864 PMC: 11775016. DOI: 10.1007/s12016-024-09017-y.
Biallelic PI4KA variants cause neurological, intestinal and immunological disease.
Salter C, Cai Y, Lo B, Helman G, Taylor H, McCartney A Brain. 2021; 144(12):3597-3610.
PMID: 34415310 PMC: 8719846. DOI: 10.1093/brain/awab313.